APOBEC3B and cancer: These observations form the basis for a model where A3B expression contributes to the accumulation of somatic alterations during the process of carcinogenesis and subsequent evolution, and it has been suggested that inhibition of this activity could represent a strategy for cancer prevention or an adjuvant to other therapies [3,144].